Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
HLF vs BHST: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HLF Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)
HLF Overall Winner
6-Pillar Tally: HLF 5 – 1 BHST
Matrix Metrics: HLF 9 – 1 BHST
As of Nov 20, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HLF carries a Unified Composite Score of 47.4/100 (HOLD) at $15.53 (5.1x Forward P/E, 9.8% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin).
- Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. HLF 47.4/100 HOLD), HLF captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -18.0% operating margin) and revenue trajectory (+6.0% vs. +3.8% YoY).
- Technical & Structure Timing Caution: HLF trades in a Markup technical trend (SURGE options phase, RSI 59.0); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HLF vs BHST
HLF
Head-to-Head Winner
Herbalife Ltd.
$15.53
-0.26% 1D
Market Cap
$1.6B
TTM Revenue
$5.28B
Forward P/E
5.1x
Beta / 30D Vol
1.02β · 50% Vol
Unified Composite Score
47.4
HOLD
Tech 31.0
Fund 46.0
Flow 60.0
Mom 50.0
Weinstein Technical Phase
Markup · Hold / add on dips
BHST
BioHarvest Sciences Inc. Common Stock
$1.30
-1.52% 1D
Market Cap
$29.9M
TTM Revenue
$35M
Forward P/E
N/M
Beta / 30D Vol
0.25β · 86% Vol
Unified Composite Score
58.2
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (HLF 5 – 1 BHST)
1. Valuation Multiples
HLF
Forward P/E
5.1x
N/M
Trailing P/E
9.2x
N/M
PEG Ratio
0.61x
N/M
EV / Revenue
0.6x
0.7x
2. Growth & Scale
HLF
Revenue Growth (YoY)
+6.0%
+3.8%
Earnings Growth (YoY)
+31.5%
+0.0%
TTM Revenue (USD)
$5.28B
$35M
Market Cap
$1.6B
$29.9M
3. Profitability & Quality
HLF
Gross Margin
77.6%
59.0%
Operating Margin
9.8%
-18.0%
Net Profit Margin
3.4%
-31.2%
Return on Equity (ROE)
0.0%
-142.5%
4. Balance Sheet & Cash Flow
HLF
Cash Generation (TTM)
$337M
-$9.4M
Cash Flow Margin
6.4%
-26.6%
Net Cash / Leverage
$1.70B Net Debt
$5.1M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
HLF
Options Structure Phase
SURGE
UNCLASSIFIED
Current IV / %ile
47.1% (4th %ile)
N/A (N/A)
Put/Call OI Skew
0.23x (Call-Skewed)
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
BHST
OpEx & R&D Intensity
67.8% of Rev ($3.58B)
77.0% of Rev ($27M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Packaged Foods Operator
Packaged Foods Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HLF (9) vs BHST (1)| Institutional Metric | HLF | BHST | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $1.6B | $29.9M | HLF | |
| Trailing P/E Ratio | 9.2x | N/M | HLF | |
| Forward P/E Ratio | 5.1x | N/M | HLF | |
| Revenue Growth (YoY) | +6.0% | +3.8% | HLF | |
| Operating Margin (TTM) | 9.8% | -18.0% | HLF | |
| Net Profit Margin | 3.4% | -31.2% | HLF | |
| Return on Equity (ROE) | 0.0% | -142.5% | HLF | |
| 52-Week Range Position | 58% ($9–$20) | 6% ($1–$7) | HLF | |
| Beta / 30D Volatility | 1.02β · 50% Vol | 0.25β · 86% Vol | HLF | |
| Unified Institutional Score | 47.4 / 100 (HOLD) | 58.2 / 100 (HOLD) | BHST | |
| Trailing 12M Revenue (USD) | $5.28B | $35M | Scale | |
| Gross Profit Margin (TTM) | 77.6% | 59.0% | Quality | |
| PEG Ratio & EV / Revenue | 0.61x PEG · 0.6x EV/Rev | N/M PEG · 0.7x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $337M ($1.70B Net Debt) | -$9.4M ($5.1M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
HLF +35.32 pp
3M Horizon
HLF +60.04 pp
6M Horizon
HLF +91.26 pp
1Y Horizon
HLF +147.84 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | HLF Revenue | BHST Revenue | HLF Op. Margin | BHST Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $4.89B | N/A | 14.0% | N/A | HLF |
| FY2019 | $4.88B | N/A | 11.6% | N/A | HLF |
| FY2020 | $5.54B | N/A | 11.6% | N/A | HLF |
| FY2021 | $5.80B | N/A | 12.7% | N/A | HLF |
| FY2022 | $5.20B | N/A | 10.5% | N/A | HLF |
| FY2023 | $5.06B | $10M | 7.0% | -78.6% | HLF |
| FY2024 | $4.99B | $30M | 7.7% | -27.7% | HLF |
| FY2025 | $5.04B | $30M | 9.5% | -16.2% | HLF |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HLF
SURGE
Current IV
47.1%
IV Percentile
4th %ile
Put/Call OI Skew
0.23x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact HLF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
BHST
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HLF Moat Profile
Cyclical / Execution-Driven Positioning
Packaged Foods Operator
OpEx & R&D Reinvestment
67.8% of Rev ($3.58B)
90D Engineering Disclosures
0 Published
BHST Moat Profile
Cyclical / Execution-Driven Positioning
Packaged Foods Operator
OpEx & R&D Reinvestment
77.0% of Rev ($27M)
90D Engineering Disclosures
0 Published
Investor FAQ HLF vs BHST Key Questions & Quantitative Answers
As of Nov 20, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HLF carries a Unified Composite Score of 47.4/100 (HOLD) at $15.53 (5.1x Forward P/E, 9.8% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. HLF 47.4/100 HOLD), HLF captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -18.0% operating margin) and revenue trajectory (+6.0% vs. +3.8% YoY). Technical & Structure Timing Caution: HLF trades in a Markup technical trend (SURGE options phase, RSI 59.0); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
HLF leads the Growth & Scale pillar: HLF posts +6.0% YoY revenue growth and +31.5% YoY earnings growth on $5.28B TTM revenue (77.6% gross margin, 9.8% operating margin), compared with BHST at +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HLF cumulative revenue shifted +3.1% while BHST shifted +200.0%. In operating R&D and SG&A reinvestment, HLF deploys 67.8% of Rev ($3.58B) (0 90-day corporate R&D disclosures) versus 77.0% of Rev ($27M) (0 disclosures) for BHST.
HLF screens cheaper on headline valuation multiples. HLF trades at 5.1x Forward P/E, 9.2x Trailing P/E, 0.61x PEG, and 0.6x EV/Revenue (6.4% FCF margin), whereas BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HLF (0.0% ROE) versus BHST (-142.5% ROE) capital efficiency.
In options market volatility and institutional positioning, HLF carries 47.1% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.23x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.02β · 50% Vol realized risk). By comparison, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
BHST vs HLF · Reverse Pair
HLF vs NUS
· Sector Peer
HLF vs USNA
· Sector Peer
HLF vs YELP
· Sector Peer
BHST vs ACOG
· Sector Peer
BHST vs ELVA
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem